Abstract
Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13), approved for the treatment of adults with moderate-t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
